Search Results - "TRACHSEL, Eveline"
-
1
Paclitaxel Enhances Therapeutic Efficacy of the F8-IL2 Immunocytokine to EDA-Fibronectin―Positive Metastatic Human Melanoma Xenografts
Published in Cancer research (Chicago, Ill.) (01-04-2012)“…The selective delivery of bioactive agents to tumors reduces toxicity and enhances the efficacy of anticancer therapies. In this study, we show that the…”
Get full text
Journal Article -
2
Antibody-Mediated Delivery of Interleukin-2 to the Stroma of Breast Cancer Strongly Enhances the Potency of Chemotherapy
Published in Clinical cancer research (15-10-2008)“…Purpose: There is an interest in the discovery of biopharmaceuticals, which are well tolerated and which potentiate the action of anthracyclines and taxanes in…”
Get full text
Journal Article -
3
Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis
Published in Arthritis research & therapy (01-01-2009)“…In this article, we present a comparative immunohistochemical evaluation of four clinical-stage antibodies (L19, F16, G11 and F8) directed against splice…”
Get full text
Journal Article -
4
In vivo Imaging of Inflammation- and Tumor-Induced Lymph Node Lymphangiogenesis by Immuno―Positron Emission Tomography
Published in Cancer research (Chicago, Ill.) (01-11-2010)“…Metastasis to regional lymph nodes (LN) is a prognostic indicator for cancer progression. There is a great demand for sensitive and noninvasive methods to…”
Get full text
Journal Article -
5
Selective occlusion of tumor blood vessels by targeted delivery of an antibody‐photosensitizer conjugate
Published in International journal of cancer (01-04-2006)“…The irregular vasculature and high interstitial pressure of solid tumors hinder the delivery of cytotoxic agents to cancer cells. As a consequence, the doses…”
Get full text
Journal Article -
6
Portable Albumin Binder from a DNA-Encoded Chemical Library
Published in Angewandte Chemie (International ed.) (01-01-2008)Get full text
Journal Article -
7
The antibody-mediated targeted delivery of interleukin-15 and GM-CSF to the tumor neovasculature inhibits tumor growth and metastasis
Published in Cancer research (Chicago, Ill.) (15-05-2007)“…Tumor-targeting immunocytokines represent a new class of anticancer pharmaceutical agents, which often display a superior therapeutic index compared with the…”
Get full text
Journal Article -
8
An engineered antibody–interleukin‐12 fusion protein with enhanced tumor vascular targeting properties
Published in International journal of cancer (01-11-2006)“…The antibody‐mediated targeted delivery of interleukin‐12 (IL12) to the EDB domain of fibronectin, a marker of angiogenesis, is a promising avenue for…”
Get full text
Journal Article -
9
The antibody-mediated targeted delivery of interleukin-10 inhibits endometriosis in a syngeneic mouse model
Published in Human reproduction (Oxford) (01-09-2011)“…BACKGROUND Endometriosis is still a highly underdiagnosed disease, and the current medical and surgical treatment of endometriosis is associated with a high…”
Get full text
Journal Article -
10
A high‐affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo‐vasculature in vivo
Published in International journal of cancer (01-06-2008)“…The alternatively spliced extra‐domain B of fibronectin is one of the best characterized markers of tumor angiogenesis. Similarly, the extra‐domain A (EDA),…”
Get full text
Journal Article -
11
Complete eradication of human B-cell lymphoma xenografts using rituximab in combination with the immunocytokine L19-IL2
Published in Blood (05-03-2009)“…The antibody-mediated delivery of therapeutic agents to sites of angiogenesis is an attractive strategy for anticancer therapy, but is largely unexplored in…”
Get full text
Journal Article -
12
A Dose-Escalation and Signal-Generating Study of the Immunocytokine L19-IL2 in Combination with Dacarbazine for the Therapy of Patients with Metastatic Melanoma
Published in Clinical cancer research (15-12-2011)“…L19-IL2 is an immunocytokine composed of an antibody fragment specific to the EDB domain of fibronectin, a tumor angiogenesis marker, and of human…”
Get full text
Journal Article -
13
Antibodies for angiogenesis inhibition, vascular targeting and endothelial cell transcytosis
Published in Advanced drug delivery reviews (07-08-2006)“…The endothelium is increasingly recognized as a target for biomedical intervention, not only for its accessibility to molecular agents coming from the…”
Get full text
Journal Article -
14
The tumour-targeting human L19-IL2 immunocytokine: Preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma
Published in European journal of cancer (1990) (01-11-2010)“…Abstract Background L19-IL2, a tumour-targeting immunocytokine composed of the recombinant human antibody fragment L19 (specific to the alternatively-spliced…”
Get full text
Journal Article -
15
Radretumab radioimmunotherapy in patients with brain metastasis: a 124I-L19SIP dosimetric PET study
Published in Cancer immunology research (01-08-2013)“…Radioimmunotherapy (RIT) with (131)I-labeled L19SIP (radretumab; a small immunoprotein format antibody directed against the ED-B domain of fibronectin; ∼ 80…”
Get more information
Journal Article -
16
Antibody-mediated delivery of IL-10 inhibits the progression of established collagen-induced arthritis
Published in Arthritis research & therapy (01-01-2007)“…The antibody-mediated targeted delivery of cytokines to sites of disease is a promising avenue for cancer therapy, but it is largely unexplored for the…”
Get full text
Journal Article -
17
Expression, engineering and characterization of the tumor-targeting heterodimeric immunocytokine F8-IL12
Published in Protein engineering, design and selection (01-08-2010)“…Proinflammatory cytokines have been used for several years in patients with advanced cancer but their administration is typically associated with severe…”
Get full text
Journal Article -
18
A Human mAb Specific to Oncofetal Fibronectin Selectively Targets Chronic Skin Inflammation In Vivo
Published in Journal of investigative dermatology (01-04-2007)“…The antibody-based targeted delivery of bioactive agents to sites of angiogenesis is an attractive therapeutic strategy for cancer treatment, but is largely…”
Get full text
Journal Article -
19
Targeting the extradomain A of fibronectin allows identification of vascular resistance to antiangiogenic therapy in experimental glioma
Published in Oncotarget (12-06-2018)“…Clinical application of antiangiogenic therapy lacks direct visualization of therapy efficacy and vascular resistance. We aimed to establish molecular imaging…”
Get full text
Journal Article -
20